BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24765887)

  • 1. First case report of acute generalized exanthematous pustulosis due to intravenous iopromide.
    Bavbek S; Sözener ZC; Aydin O; Ozdemir SK; Gül U; Heper AO
    J Investig Allergol Clin Immunol; 2014; 24(1):66-7. PubMed ID: 24765887
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis induced by iomeprol with cross-reactivity to other iodinated contrast agents and mild reactions after rechallenge with iopromide and oral corticosteroid premedication.
    Machet P; Marcé D; Ziyani Y; Dumont M; Cornillier H; Jonville-Bera AP; Machet L
    Contact Dermatitis; 2019 Jul; 81(1):74-76. PubMed ID: 30762885
    [No Abstract]   [Full Text] [Related]  

  • 3. Iodinated contrast media-induced acute generalized exanthematous pustulosis confirmed by delayed skin tests.
    Grandvuillemin A; Ripert C; Sgro C; Collet E
    J Allergy Clin Immunol Pract; 2014; 2(6):805-6. PubMed ID: 25439379
    [No Abstract]   [Full Text] [Related]  

  • 4. First case report of acute generalized exanthematous pustulosis due to labetalol.
    Gómez Torrijos E; García Rodríguez C; Sánchez Caminero MP; Castro Jiménez A; García Rodríguez R; Feo-Brito F
    J Investig Allergol Clin Immunol; 2015; 25(2):148-9. PubMed ID: 25997315
    [No Abstract]   [Full Text] [Related]  

  • 5. First case of acute generalized exanthematous pustulosis caused by pitavastatin: possible pathogenetic role of IL-36.
    Saito-Sasaki N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Eur J Dermatol; 2016; 26(1):106-7. PubMed ID: 26679546
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test.
    Salman A; Yucelten D; Akin Cakici O; Kepenekli Kadayifci E
    Pediatr Dermatol; 2019 Jul; 36(4):514-516. PubMed ID: 31050838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol hypersensitivity syndrome with acute generalized exanthematous pustulosis manifestations.
    Teo WL; Pang SM; Koh HY
    Cutan Ocul Toxicol; 2011 Sep; 30(3):243-4. PubMed ID: 21345152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis due to dextromethorphan.
    Otero Rivas MM; Sánchez Sambucety P; García-Ruiz de Morales JM; Pérez Paredes G; Rodríguez Prieto MA
    Dermatol Online J; 2013 Oct; 19(10):20030. PubMed ID: 24139370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute generalized exanthematous pustulosis. Study of 22 cases].
    Mebazaa A; Kort R; Zaiem A; Elleuch D; Moula H; Cheikhrouhou R; Trojjet S; Mokni M; Ben Osman A; Daghfous R
    Tunis Med; 2010 Dec; 88(12):910-5. PubMed ID: 21136359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute generalized exanthematous pustulosis caused by radiocontrast media.
    Kim SJ; Lee T; Lee YS; Bae YJ; Cho YS; Moon HB; Kim TB
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):492-3. PubMed ID: 21130392
    [No Abstract]   [Full Text] [Related]  

  • 11. A severe case of acute generalized exanthematous pustulosis (AGEP) in a child after the administration of amoxicillin-clavulanic acid: brief report.
    Riten K; Shahina Q; Jeannette J; Palma-Diaz MF
    Pediatr Dermatol; 2009; 26(5):623-5. PubMed ID: 19840330
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis induced by gliclazide: a case report.
    Contreras-Steyls M; Vílchez-Márquez F; Mota A; Moyano B; Herrera-Ceballos E
    Int J Dermatol; 2013 Dec; 52(12):1591-3. PubMed ID: 24261739
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Generalized Exanthematous Pustulosis Caused by Faropenem: A Possible Pathogenetic Role for Interleukin-23.
    Sakuragi Y; Sawada Y; Hara Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Acta Derm Venereol; 2016 Feb; 96(2):265-6. PubMed ID: 26302837
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts.
    Speeckaert MM; Speeckaert R; Lambert J; Brochez L
    Eur J Dermatol; 2010; 20(4):425-33. PubMed ID: 20542841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of generalized pustular psoriasis that might have progressed from terbinafine-induced acute generalized exanthematous pustulosis.
    Yasuno S; Yamaguchi M; Tanaka A; Umehara K; Okita T; Asano N; Kashiwagi K; Shimomura Y
    J Dermatol; 2018 Dec; 45(12):e328-e329. PubMed ID: 29766566
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-pigmenting fixed drug eruption with mixed features of acute generalized exanthematous pustulosis induced by pseudoephedrine: a case report.
    Fukuda R; Ouchi T; Hirai I; Funakoshi T; Honda A; Tanese K; Tanikawa A; Amagai M; Takahashi H
    Contact Dermatitis; 2017 Aug; 77(2):123-126. PubMed ID: 28703347
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis associated with terbinafine: a case report.
    Turan H; Acer E; Erdem H; Uslu E; Aliagaoglu C
    Cutan Ocul Toxicol; 2013 Oct; 32(4):325-6. PubMed ID: 23432048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is acute generalized exanthematous pustulosis an uncommon condition in childhood?
    Ozmen S; Misirlioglu ED; Gurkan A; Arda N; Bostanci I
    Allergy; 2010 Nov; 65(11):1490-2. PubMed ID: 20486903
    [No Abstract]   [Full Text] [Related]  

  • 19. Accidental re-exposure causing repeated severe acute generalized exanthematous pustulosis.
    O'Driscoll D; Foria V; Fityan A; Ardern-Jones M
    Clin Exp Dermatol; 2019 Dec; 44(8):927-929. PubMed ID: 30817022
    [No Abstract]   [Full Text] [Related]  

  • 20. Nystatin-induced acute generalized exanthematous pustulosis.
    Ocerin-Guerra I; Gomez-Bringas C; Aspe-Unanue L; Ratón-Nieto JA
    Actas Dermosifiliogr; 2012 Dec; 103(10):927-8. PubMed ID: 23149047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.